Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 237 publications
Adjuvant Pembrolizumab for Stage IIB or IIC Melanoma: A Secondary Analysis of a Randomized Clinical Trial.
Journal: JAMA network open
Published: February 17, 2026
Priorities for local immunotherapy research and drug development.
Journal: Journal for immunotherapy of cancer
Published: January 31, 2026
Unlocking the promise of innate biology through the HLA-G/ILT2/ILT4 pathway.
Journal: Journal for immunotherapy of cancer
Published: January 27, 2026
Cytokine Release Symptoms rather than Syndromes: A call for Granular Reporting of Cytokine Related Adverse Events in Clinical Trials.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 26, 2026
Cytokine release symptoms rather than syndromes: a call for granular reporting of cytokine-related adverse events in clinical trials.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 26, 2026
Advancing Cell Therapies for Solid Tumors: A Pathway to Overcome Biological, Operational, and Regulatory Hurdles.
Journal: Transplantation and cellular therapy
Published: December 04, 2025
Lead-in therapy targeting PD1 and/or LAG3 imposes distinct immune phenotypes in first-line treatment of metastatic melanoma.
Journal: medRxiv : the preprint server for health sciences
Published: November 24, 2025
Multiregional CT Features Improve Prediction of Immunotherapy Response in Advanced Melanoma.
Journal: medRxiv : the preprint server for health sciences
Published: November 24, 2025
Phase 1 open-label study of ASP9801, an oncolytic virus, in patients with advanced or metastatic solid tumors.
Journal: Journal for immunotherapy of cancer
Published: November 13, 2025
Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid Tumors.
Journal: Cancer research communications
Published: September 22, 2025
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations.
Journal: medRxiv : the preprint server for health sciences
Published: August 08, 2025
Erratum: Beyond Checkpoint Inhibition: Keeping Therapeutic Options Open.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: August 08, 2025
Last Updated: 09/26/2026